Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lidocaine + amylmetacresol + 2,4-dichlorobenzyl alcohol
- Development stage
- Unknown
- Lead developer
- Reckitt
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Inovox is an over-the-counter (OTC) combination pharmaceutical product developed and marketed by USP Zdrowie for the symptomatic relief of sore throat and mouth infections. The formulation typically includes lidocaine hydrochloride, a local anesthetic that provides rapid pain relief by inhibiting voltage-gated sodium channels, thereby blocking nerve impulse conduction in the oropharynx. It also contains two antiseptic agents, amylmetacresol and 2,4-dichlorobenzyl alcohol, which exhibit broad-spectrum antimicrobial activity against bacteria and viruses associated with throat infections. Inovox is available in lozenge form and is indicated for adults and children to alleviate pain and inflammation in the throat.
- Brand names
- InovoxInovox Express
02
Targets
Microbial membranes and viral envelopesNaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on lidocaine + amylmetacresol + 2,4-dichlorobenzyl alcohol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lidocaine + amylmetacresol + 2,4-dichlorobenzyl alcohol.